循环病毒粒子RNA和细胞相关病毒DNA的周转反映了1型人类免疫缺陷病毒感染个体中的活跃病毒复制。
Turnover of circulating virion RNA and of cell-associated viral DNA reflects active viral replication in human immunodeficiency virus type 1-infected individuals.
作者信息
Lineberger D W, Kessler J A, Waterbury J A, Byrnes V W, Massari F, Staszewski S, Emini E A
机构信息
Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania 19486.
出版信息
J Virol. 1995 Apr;69(4):2637-9. doi: 10.1128/JVI.69.4.2637-2639.1995.
Abstract
A quantitative assessment of human immunodeficiency virus type 1 turnover in patient cell-free virion and infected-cell compartments under the dynamic conditions imposed by an effective antiviral therapy was performed. The turnover was rapid, and following a temporal lag, the extent of viral population replacement was eventually similar in both compartments. Each compartment therefore reflects considerable active virus replication.
摘要
在有效抗病毒治疗所施加的动态条件下，对患者游离病毒体和感染细胞区室中1型人类免疫缺陷病毒的周转进行了定量评估。周转速度很快，经过一段时间的延迟后，两个区室中病毒种群替换的程度最终相似。因此，每个区室都反映了相当活跃的病毒复制。
相似文献
1
Turnover of circulating virion RNA and of cell-associated viral DNA reflects active viral replication in human immunodeficiency virus type 1-infected individuals.循环病毒粒子RNA和细胞相关病毒DNA的周转反映了1型人类免疫缺陷病毒感染个体中的活跃病毒复制。
J Virol. 1995 Apr;69(4):2637-9. doi: 10.1128/JVI.69.4.2637-2639.1995.
2
A nonnucleoside reverse transcriptase inhibitor active on human immunodeficiency virus type 1 isolates resistant to related inhibitors.一种对1型人类免疫缺陷病毒分离株具有活性的非核苷类逆转录酶抑制剂，该分离株对相关抑制剂耐药。
Antimicrob Agents Chemother. 1993 May;37(5):947-9. doi: 10.1128/AAC.37.5.947.
3
Clinical experience with non-nucleoside reverse transcriptase inhibitors: L-697,661 and nevirapine.非核苷类逆转录酶抑制剂的临床经验：L-697,661和奈韦拉平。
Adv Exp Med Biol. 1996;394:291-8. doi: 10.1007/978-1-4757-9209-6_26.
4
A new series of pyridinone derivatives as potent non-nucleoside human immunodeficiency virus type 1 specific reverse transcriptase inhibitors.一类新型吡啶酮衍生物作为有效的非核苷类1型人类免疫缺陷病毒特异性逆转录酶抑制剂。
J Med Chem. 1995 Nov 10;38(23):4679-86. doi: 10.1021/jm00023a007.
5
The appearance of drug resistance-associated point mutations in HIV type 1 plasma RNA precedes their appearance in proviral DNA.1型人类免疫缺陷病毒（HIV-1）血浆RNA中与耐药相关的点突变在其于前病毒DNA中出现之前就已出现。
AIDS Res Hum Retroviruses. 1995 Oct;11(10):1221-5. doi: 10.1089/aid.1995.11.1221.
6
The genetic and functional basis of HIV-1 resistance to nonnucleoside reverse transcriptase inhibitors.HIV-1对非核苷类逆转录酶抑制剂耐药的遗传及功能基础。
Arch Virol Suppl. 1994;9:11-7. doi: 10.1007/978-3-7091-9326-6_2.
7
Viral dynamics in human immunodeficiency virus type 1 infection.1型人类免疫缺陷病毒感染中的病毒动力学
Nature. 1995 Jan 12;373(6510):117-22. doi: 10.1038/373117a0.
8
Marked infidelity of human immunodeficiency virus type 1 reverse transcriptase at RNA and DNA template ends.1型人类免疫缺陷病毒逆转录酶在RNA和DNA模板末端存在明显的错配。
Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):549-53. doi: 10.1073/pnas.91.2.549.
9
Progression of early steps of human immunodeficiency virus type 1 replication in the presence of an inhibitor of viral protease.在存在病毒蛋白酶抑制剂的情况下，人类免疫缺陷病毒1型复制早期步骤的进展
J Virol. 1992 Aug;66(8):5087-91. doi: 10.1128/JVI.66.8.5087-5091.1992.
10
Viral DNA carried by human immunodeficiency virus type 1 virions.1型人类免疫缺陷病毒病毒粒子携带的病毒DNA。
J Virol. 1992 Aug;66(8):5067-74. doi: 10.1128/JVI.66.8.5067-5074.1992.
引用本文的文献
1
Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS.人类免疫缺陷病毒1型准种在进展至艾滋病过程中的进化减缓。
J Virol. 1997 Oct;71(10):7498-508. doi: 10.1128/JVI.71.10.7498-7508.1997.
2
Nevirapine-resistant human immunodeficiency virus: kinetics of replication and estimated prevalence in untreated patients.奈韦拉平耐药的人类免疫缺陷病毒：未治疗患者中的复制动力学及估计患病率
J Virol. 1996 Nov;70(11):7894-9. doi: 10.1128/JVI.70.11.7894-7899.1996.
本文引用的文献
1
Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection.初次感染时对1型人类免疫缺陷病毒外膜蛋白中特定序列的选择。
J Virol. 1993 Jun;67(6):3345-56. doi: 10.1128/JVI.67.6.3345-3356.1993.
2
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease.在疾病的临床潜伏期，HIV感染在淋巴组织中活跃且呈进行性发展。
Nature. 1993 Mar 25;362(6418):355-8. doi: 10.1038/362355a0.
3
Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS.在艾滋病潜伏期，人类免疫缺陷病毒对辅助性T淋巴细胞和巨噬细胞进行大量隐匿性感染。
Nature. 1993 Mar 25;362(6418):359-62. doi: 10.1038/362359a0.
4
Comprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitors.1型人类免疫缺陷病毒逆转录酶对非核苷类抑制剂耐药性的综合突变酶和病毒变体评估
Antimicrob Agents Chemother. 1993 Aug;37(8):1576-9. doi: 10.1128/AAC.37.8.1576.
5
A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group.HIV-1逆转录酶非核苷抑制剂L-697,661的短期临床评估。L-697,661研究小组
N Engl J Med. 1993 Oct 7;329(15):1065-72. doi: 10.1056/NEJM199310073291502.
6
A mutation in human immunodeficiency virus reverse transcriptase and decline in CD4 lymphocyte numbers in long-term zidovudine recipients.
J Infect Dis. 1993 Mar;167(3):526-32. doi: 10.1093/infdis/167.3.526.
7
The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.人类免疫缺陷病毒：传染性与发病机制
Science. 1988 Feb 5;239(4840):617-22. doi: 10.1126/science.3277274.
8
9
Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral and lymphocyte-associated proviral populations in vivo: implications for models of HIV pathogenesis.人类免疫缺陷病毒1型（HIV-1）包膜基因序列在体内血浆病毒和淋巴细胞相关前病毒群体中的间断性序列变化：对HIV发病机制模型的启示
J Virol. 1991 Nov;65(11):6266-76. doi: 10.1128/JVI.65.11.6266-6276.1991.
10
NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection.美国国立卫生研究院会议。人类免疫缺陷病毒（HIV）感染中的免疫致病机制。
Ann Intern Med. 1991 Apr 15;114(8):678-93. doi: 10.7326/0003-4819-114-8-678.
Zotero 插件